Examkin

Question

Difficulty: HardPediatric Infectious Diseases

A 2-month-old male infant is brought to the clinic for a routine well-child examination. The patient was recently diagnosed with severe combined immunodeficiency (SCID) following an abnormal newborn screen and confirmatory flow cytometry. His mother reports that over the past two days, he has developed nasal congestion, a mild cough, and noisy breathing. She also expresses concern about a rash on his face that appeared at 3 weeks of age and has persisted. He is afebrile and feeding well. Vital signs show a heart rate of 130/min, respiratory rate of 42/min, and oxygen saturation of 97% on room air. Physical examination reveals small, scattered erythematous papules and pustules without comedones, limited strictly to his cheeks and forehead. Lung auscultation demonstrates mild, diffuse bilateral expiratory wheezes without subcostal retractions. The mother inquires about the plan for today's routine 2-month immunizations. Which of the following is the most appropriate management plan for this patient?

  1. Reassure the mother regarding the rash, advise supportive care for the respiratory symptoms, and administer only the routine inactivated vaccines while withholding the rotavirus vaccine.Answer
  2. B
    Prescribe a trial of nebulized albuterol for the respiratory symptoms, reassure the mother regarding the rash, and administer only the routine inactivated vaccines while withholding the rotavirus vaccine.
  3. C
    Prescribe a course of oral azithromycin for the respiratory symptoms, reassure the mother regarding the rash, and administer only the routine inactivated vaccines while withholding the rotavirus vaccine.
  4. D
    Prescribe topical mupirocin for the facial rash, advise supportive care for the respiratory symptoms, and administer only the routine inactivated vaccines while withholding the rotavirus vaccine.
  5. E
    Reassure the mother regarding the rash, advise supportive care for the respiratory symptoms, and administer all routine 2-month vaccines, including the rotavirus vaccine.

Answer

The most appropriate management plan is to reassure the mother regarding the rash, advise supportive care for the respiratory symptoms, and administer only the routine inactivated vaccines while withholding the rotavirus vaccine.
The correct management synthesizes three distinct clinical evaluations. First, the rash appearing at 3 weeks composed of papules and pustules on the face is neonatal cephalic pustulosis, a benign condition requiring only reassurance. Second, the mild upper respiratory symptoms and wheezing without hypoxia or retractions indicate mild viral bronchiolitis, for which guidelines recommend strictly supportive care (e.g., nasal suctioning and hydration) over bronchodilators or antibiotics. Finally, because the infant has severe combined immunodeficiency (SCID), he has a profound T-cell defect. The routine 2-month rotavirus vaccine is live-attenuated and therefore absolutely contraindicated to prevent severe vaccine-strain disease. Inactivated vaccines (like DTaP, IPV, PCV, Hib, and HepB) are safe to administer, though their immunogenicity may be reduced.

Step-by-Step Solution

1
Evaluate the infant's facial rash.
The rash is identified as neonatal cephalic pustulosis (neonatal acne).
The appearance of erythematous papules and pustules without comedones on the cheeks and forehead at approximately 3 weeks of age is classic for this benign condition, which requires only reassurance.
2
Assess the acute respiratory symptoms and vital signs.
The patient has mild viral bronchiolitis.
Nasal congestion, cough, and mild expiratory wheezing in a 2-month-old with normal oxygen saturation and no increased work of breathing strongly suggest a mild viral etiology (e.g., RSV). Management is purely supportive.
3
Determine the appropriate immunization strategy based on the patient's underlying condition.
Live vaccines must be withheld, while inactivated vaccines may be administered.
The patient has severe combined immunodeficiency (SCID), representing a profound T-cell defect. Live-attenuated vaccines, such as the routine 2-month rotavirus vaccine, are absolutely contraindicated due to the risk of severe vaccine-strain disseminated infection.

Key Concept

In patients with severe combined immunodeficiency (SCID), live-attenuated vaccines (like rotavirus) are strictly contraindicated. Furthermore, benign conditions like neonatal cephalic pustulosis and mild viral bronchiolitis require supportive care rather than pharmacologic intervention.
Estimated Time:2m 0s
Rate this question

Topics

Pediatric Infectious Diseases

More questions from this topic